K. Dhatariya, S.C. Bain, R.E. Pratley, J.B. Buse, R. Simpson, L. Tarnow, M. Stellfeld, M.S. Kaltoft, K. Tornøe, on behalf of the LEADER Trial. Exploring the impact of liraglutide on diabetic foot ulcers on subjects with type 2 diabetes and increased risk of cardiovascular events: results from the LEADER trial. 53rd EASD Annual Meeting, 2017.
S. Bain, E. Araki, C. Desouza, S. Garg, L. Rose, G. Tsoukas, E. Bergan, J. Derving Karsbøl, J. DeVries. Semaglutide reduces HbA1c and body weight across baseline HbA1c subgroups in the SUSTAIN 1-5 clinical trials. 53rd EASD Annual Meeting, 2017.
F. Flacke, S. Edelman, S. Bain, C. Hasslacher, G. Charpentier, G. Vespasiani, H. Goyeau, M. Woloschak, M. Davies. Device-supported vs routine titration of insulin glargine 300 U/ml (Gla-300) in type 2 diabetes: efficacy and safety. 53rd EASD Annual Meeting, 2017.
O. Moser, O. McCarthy, R. Deere, M.L. Eckstein, S.C. Bain, H.L. Haahr, E. Zijlstra, T. Heise, R.M. Bracken. Poor glycaemic control is associated with altered physiological responses during cardio-pulmonary exercise testing in type 1 diabetes. 53rd EASD Annual Meeting, 2017.
A. Consoli, S.C. Bain, M. Davies, I. Lingvay, E.Q. Bergan, O. Hansen, T. Vilsbøll. Semaglutide provides sustained reductions in body weight over 2 years in subjects with type 2 diabetes (SUSTAIN 6). 53rd EASD Annual Meeting, 2017.
Vinay S. Eligar, Peter Taylor, Arshiya Tabasum, Preethi Nalla, Angeliki Giannopoulou, Sam Rice, Kofi Obuobie, Aled Roberts, Anil Kumar Pura Narayanaswamy, Neera Agarwal, Julia Platts. Predicting Inpatient Hypoglycaemia Risk with Cardiff Hypoglycaemia Risk Score (CHRiS). American Diabetes Association 77th Scientific Conference, 2017
Brian M. Frier, Wolfgang Landgraf, Jason Chao, David R. Owens, Geremia B. Bolli. Comparison of Outcomes in People with T2D Treated with Insulin Glargine 100 U/mL According to Fasting Plasma Glucose Levels Achieved during Study Maintenance Period: A Pooled Analysis of Sixteen RCTs. American Diabetes Association 77th Scientific Conference, 2017.
David R. Owens, Wolfgang Landgraf, Mei Zhang, Louise Traylor, Brian M. Frier, Geremia B. Bolli, Philip D. Home. Association of Fasting C-Peptide Levels with Glycemic Efficacy and Risk of Hypoglycemia in People with T2DM Commencing Insulin Glargine 100 U/mL. American Diabetes Association 77th Scientific Conference, 2017
Nalisha Monroe, Rebecca L. Thomas, Vishwamitra Ramdath, Ronnie Bhola, David R. Owens. Findings from a Pilot Diabetic Retinopathy Screening Service in the South West Regional Health Authority in Trinidad and Tobago: A Basis for a National Programme. American Diabetes Association 77th Scientific Conference, 2017
Guillaume Noyel, Michel Jourlin, Michel Smans, Rebecca L. Thomas, Simon Iles, Gavin Bhakta, Andrew Crowder, David R. Owens, Peter Boyle. Enhancing Eye Fundus Images for Diabetic Retinopathy Screening. American Diabetes Association 77th Scientific Conference, 2017